AU2017902291A0 - Antibody-Drug-Conjugates And Uses Thereof For The Treatment of Cancer - Google Patents

Antibody-Drug-Conjugates And Uses Thereof For The Treatment of Cancer

Info

Publication number
AU2017902291A0
AU2017902291A0 AU2017902291A AU2017902291A AU2017902291A0 AU 2017902291 A0 AU2017902291 A0 AU 2017902291A0 AU 2017902291 A AU2017902291 A AU 2017902291A AU 2017902291 A AU2017902291 A AU 2017902291A AU 2017902291 A0 AU2017902291 A0 AU 2017902291A0
Authority
AU
Australia
Prior art keywords
conjugates
antibody
cancer
drug
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017902291A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bionomics Ltd
Original Assignee
Bionomics Ltd
Filing date
Publication date
Application filed by Bionomics Ltd filed Critical Bionomics Ltd
Publication of AU2017902291A0 publication Critical patent/AU2017902291A0/en
Abandoned legal-status Critical Current

Links

AU2017902291A 2017-06-16 Antibody-Drug-Conjugates And Uses Thereof For The Treatment of Cancer Abandoned AU2017902291A0 (en)

Publications (1)

Publication Number Publication Date
AU2017902291A0 true AU2017902291A0 (en) 2017-06-29

Family

ID=

Similar Documents

Publication Publication Date Title
EP3570844A4 (en) Azolopyrimidine for the treatment of cancer-related disorders
EP3630089A4 (en) Methods of cancer treatment
EP3325473A4 (en) Compounds and uses thereof in the treatment of cancers and other medical conditions
EP3720502A4 (en) Cytobiologics and therapeutic uses thereof
EP3402516A4 (en) Use of siglec-7 or siglec-9 antibodies for the treatment of cancer
EP3894392A4 (en) Compositions and methods for the treatment of cancer
EP3565558A4 (en) Combination therapy for the treatment of cancer
EP3307240A4 (en) Combination therapy for the treatment of cancer
EP3432888A4 (en) Treatment of cancer with tg02
EP3436002A4 (en) Pharmaceutical combinations for the treatment of cancer
EP3359192A4 (en) Combination therapy for the treatment of cancer
EP3585817A4 (en) Compositions and methods for treatment of cancer
EP3600393A4 (en) Combination therapy for the treatment of solid and hematological cancers
EP3157336A4 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of ovarian cancer
EP3548028A4 (en) Treatment of cancer
EP3615056A4 (en) Methods and agents for the detection and treatment of cancer
EP3478284A4 (en) Compounds and compositions for the treatment of cancer
EP3490561A4 (en) Combinations for the treatment of cancer
EP3820492A4 (en) Apmv and uses thereof for the treatment of cancer
EP3503887A4 (en) Combinations for the treatment of cancer
EP3411122A4 (en) Cancer vaccines and methods of treatment using the same
IL280587B (en) Flurocytidine derivatives and its composition for the treatment of cancer
EP3472623A4 (en) Exosome-guided treatment of cancer
EP3185910A4 (en) Methods and compositions for the treatment of cancer
EP3688023A4 (en) Methods and compositions for cancer treatment